|
|
Spironolactone in improving cardiovascular function in patients on hemodialysis |
XIE Longhui1,WANG Shufang1,ZHAO Jianrong2,and DONG Yi1 |
1.Internal Medicine,Armed Police Inner Mongolia Autonomous Region Corps Hospital,Hohhot 010020,China; 2.Nephrology Department,The Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China |
|
|
Abstract Objective To explore the effect of spironolactone used in the process of hemodialysis on the cardiovascular function of patients.Methods Betweem January 2017 and January 2018, 98 cases of chronic kidney disease patients were admitted to our hospital, who were randomly divided into the observation group (n=49) and control group (n=49).Maintenance dialysis was adopted in both groups. During dialysis, the control group was given oral placebo, while the observation group was given oral spironolactone. Changes of cardiovascular function and related complications were observed in both groups before and after treatment.Results Three months after treatment, the cardiac function and blood vessel function significantly improved in the observation group. There was statistically significant difference between the observation group and the control group after treatment (P<0.05).The incidence of complications during hemodialysis was 4.08%, much lower than 18.37% of the control group (P<0.05).Conclusions In the course of hemodialysis, oral spironolactone can improve patients’ cardiovascular function and reduce complications.
|
Received: 14 March 2019
|
|
|
|
|
[1] |
周晓铎. 终末期肾病血液透析患者应用螺内酯的安全性及对心血管保护作用的meta分析[D].南宁:广西医科大学,2016.
|
[2] |
宋小丽,蔡梦瑶.血液透析时应用螺内酯对患者心功能、透析充分性及并发症的影响[J]. 现代医药卫生,2017,33(19):2947-2949.
|
[3] |
王建中.螺内酯对腹膜透析患者的长期效应[J].中华肾病研究电子杂志,2014,3(3):169.
|
[4] |
Ni X,Zhang J,Zhang P,等. 螺内酯对接受透析治疗的顽固性高血压患者的效用[J].心血管病学进展,2015,36(6):765.
|
[5] |
彭 勇. 终末期肾病血液透析患者应用螺内酯的安全性与有效性分析[J].人人健康, 2018,26(4):26-27.
|
[6] |
刘苑苹,包蓓艳,李国富.小剂量螺内酯在腹膜透析低钾血症患者中的应用[J].中国中西医结合肾病杂志,2017,18(8):715-717.
|
[7] |
陈 敏,蒋 雯.螺内酯对慢性心力衰竭患者心脏自主神经功能的影响[J].中国医院药学杂志,2016,36(22):2004-2007.
|
[8] |
王自豪.螺内酯片联合美托洛尔片改善老年慢性心力衰竭患者左室重构及心功能的效果分析[J]. 系统医学,2016,1(4):17-19.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 729-732. |
|
|
|
|